Search Results
-
Eye fluid study may foster treatments
Stanford Medicine researchers clock the age of cells to find new therapy targets.
-
Classifying a type of depression
Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.
-
New COVID-19 vaccine
In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.
-
Osteoarthritis linked to allergic inflammation
A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.
-
New app detects mpox
Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.
-
Cyclotron director dies at 43
The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.
-
Nobelist Paul Berg dies
Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.
-
Celiac expert Gary Gray dies at 89
Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.
-
Hepatitis C treatment low
Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.
-
An evening to celebrate queer joy
An Evening of Queer Joy, formerly known as the LGBTQ+ Forum, showcases the spectrum of emotions experienced by queer people.